Home › Chronic Myelomonocytic Leukemia › Maryland
Chronic Myelomonocytic Leukemia clinical trials in Maryland
3 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in Maryland.
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06904066Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- AllerVie Health, Glenn Dale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07143669Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RecruitingEarly phase 1
Ages 18 to 100 · All sexes · Updated Mar 27, 2026 · NCT07071155From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.